PANews reported on August 13th that the board of directors of biopharmaceutical company LIXTE Biotechnology Holdings has approved a strategic capital allocation plan to invest up to 25% of the company's treasury in cryptocurrencies, including Bitcoin and other digital assets. The specific transaction size and timing will be determined based on market conditions and strategic considerations.
LIXTE Biotechnology plans to invest 25% of its treasury in Bitcoin and other cryptocurrencies
Share to:
Author: PA一线
This content is for informational purposes only and does not constitute investment advice.
Follow PANews official accounts, navigate bull and bear markets together
Recommended Reading
